Trehalose: An intriguing disaccharide with potential for medical application in ophthalmology

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 577-581

  Luyckx, Jacques ^a   Baudouin, Christophe ^b  

^a Laboratoires Thea   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

Cells; Desiccation; Disaccharide; Trehalose

Indexed keywords

CYCLOSPORIN; THEALOZ; TREHALOSE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; CELL PROTECTION; CORNEA EDEMA; CRYOPRESERVATION; DESICCATION; DISEASE SEVERITY; DRUG EFFECT; DRUG STRUCTURE; DRY EYE; EPITHELIUM CELL; EYE CARE; HUMAN; HUNTINGTON CHOREA; KERATOCONJUNCTIVITIS SICCA; LIPID BILAYER; MACROMOLECULE; MAMMAL CELL; NONHUMAN; OXIDATIVE STRESS; REVIEW;

EID: 79956369750     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S18827     Document Type: Review

References (31)

1. Iturriaga G, Suárez R, Nova-Franco B. Trehalose metabolism: From osmoprotection to signaling. Int J Mol Sci. 2009; 10: 3793-3810.
2. Richards AB, Krakowka S, Dexter LB, et al. Trehalose: A review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol. 2002; 40: 871-898.
3. Elbein AD. The metabolism of alpha, alpha-trehalose. Adv Carbohydr Chem Biochem. 1974; 30: 227-256.
4. Crowe JH. Trehalose and anhydrobiosis: The early work of J. S. Clegg. J Exp Biol. 2008: 2899-2900.
5. Leidy C, Gousset K, Ricker J, et al. Lipid phase behavior and stabili- zation of domains in membranes of platelets. Cell Biochem Biophys. 2004; 40: 123-148.
6. Teramoto N, Sachinvala ND, Shibata M. Trehalose and trehalose-based polymers for environmentally benign, biocompatible and bioactive materials. Molecules. 2008; 13: 1773-1816.
7. AC. Membranes, Metabolism, and Dry Organisms. Ithaca, NY: Cornell University Press; 1986.
8. Elbein AD, Pan YT, Pastuszak I, Carroll D. New insights on trehalose: A multifunctional molecule. Glycobiology. 2003; 13: 17R-27R.
9. Crowe LM, Mouradian R, Crowe JH, Jackson SA, Womersley C. Effects of carbohydrates on membrane stability at low water activities. Biochim Biophys Acta. 1984; 769: 141-150.
10. Chen Q, Haddad GG. Role of trehalose phosphate synthase and tre- halose during hypoxia: From flies to mammals. J Exp Biol. 2004; 207: 3125-3129.
11. Jain NK, Roy I. Effect of trehalose on protein structure. Protein Sci. 2009; 18: 24-36.
12. Tanaka M, Machida Y, Niu S, et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med. 2004; 10: 148-154.
13. Yang CR, Yu RK. Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease. J Neurosci Res. 2009; 87: 26-33.
14. Izmitli A, Schebor C, McGovern MP, Reddy AS, Abbott NL, de Pablo JJ. Effect of trehalose on the interaction of Alzheimer's Aβ-peptide and anionic lipid monolayers. Biochim Biophys Acta. 2011; 1808: 26-33.
15. Reddy AS, Izmitli A, de Pablo JJ. Effect of trehalose on amyloid beta(29-40)-membrane interaction. J Chem Phys. 2009; 131: 085101
16. Benaroudj N, Lee DH, Goldberg AL. Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals. J Biol Chem. 2001; 276: 24261-24267.
17. Herdeiro RS, Pereira MD, Panek AD, Eleutherio EC. Trehalose protects Saccharomyces cerevisiae from lipid peroxidation during oxidative stress. Biochim Biophys Acta. 2006; 1760: 340-346.
18. Katenz E, Vondran FW, Schwartlander R, et al. Cryopreservation of primary human hepatocytes: The benefit of trehalose as an additional cryoprotective agent. Liver Transpl. 2007; 13: 38-45.
19. Eroglu A, Toner M, Toth TL. Beneficial effect of microinjected tre- halose on the cryosurvival of human oocytes. Fertil Steril. 2002; 77: 152-158.
20. Matsuo T. Trehalose protects corneal epithelial cells from death by drying. Br J Ophthalmol. 2001; 85: 610-612.
21. Izawa Y, Matsuo T, Uchida T, Shimamura K, Ohtsuki H. Atomic force microscopy observation of trehalose-treated and dried corneal epithelial surface. Cell Preserv Technol. 2006; 4: 117-122.
22. Chen W, Zhang X, Zhang J, et al. A murine model of dry eye induced by an intelligently controlled environmental system. Invest Ophthalmol Vis Sci. 2008; 49: 1386-1391.
23. Chen W, Zhang X, Liu M, et al. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis. Exp Eye Res. 2009; 89: 311-318.
24. Chen W. The prophylactic efficacy of trehalose compared with CsA for treatment of murine dry eye induced by ICES. Laboratoires Théa. Data on file; 2009.
25. Strong B, Farley W, Stern ME, Pflugfelder SC. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine kera- toconjunctivitis sicca. Cornea. 2005; 24: 80-85.
26. Chen W, Li JI, Zhang XB. Trehalose, anhydrobiosis for the eye. Acta Ophthalmol. 2010; 88 Suppl: s246.
27. Čejková J, Čejka Č, Ardan J, Širc J, Michálek J, Luyckx J. Reduced UVB-induced corneal damage caused by reactive oxygen and nitrogen species and decreased changes in corneal optics after trehalose treatment. Histol Histopathol. 2010; 25: 1403-1414.
28. Abbott PJ, Chen J. Trehalose. WHO food additive series 46: Available at: htpp://www.inchem.org/documents/jecfa/jecmono/v46je05.htm. Accessed December 22, 2010.
29. Matsumoto S, Noguichi H, Shimoda M, et al. Seven consecutive suc- cessful clinical islet isolations with pancreatic ductal injection. Cell Transplant. 2010; 19: 291-297.
30. Matsuo T, Tsuchida Y, Morimoto N. Trehalose eye drops in the treatment of dry eye syndrome. Ophthalmology. 2002; 109: 2024-2029.
31. Matsuo T. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye. Jpn J Ophthalmol. 2004; 48: 321-327.